Oruka Therapeutics, Inc. (ORKA): Free Cash Flow
-$88.42M
Year ended 2025-12-31
-$101.15M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$88.42M | n/a | 2026-03-12, From 2025-01-01 |
| No annual figure between 2023-12-31 and 2025-12-31. | |||
| 2023-12-31 | -$5.01M | n/m | 2024-02-01, From 2023-01-01 |
| 2022-12-31 | -$10.91M | n/m | 2024-02-01, From 2022-01-01 |
| 2021-12-31 | -$18.80M | n/m | 2023-02-24, From 2021-01-01 |
| 2020-12-31 | -$7.74M | n/m | 2022-03-14, From 2020-01-01 |
| 2019-12-31 | -$4.80M | n/m | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | -$8.25M | n/m | 2020-02-18, From 2018-01-01 |
| 2017-12-31 | -$17.48M | n/m | 2019-02-27, From 2017-01-01 |
| 2016-12-31 | -$15.00M | n/m | 2018-03-22, From 2016-01-01 |
| 2015-12-31 | -$10.54M | n/m | 2017-03-21, From 2015-01-01 |
| 2014-12-31 | -$9.43M | n/m | 2016-03-17, From 2014-01-01 |
| 2013-12-31 | -$5.32M | n/a | 2015-03-19, From 2013-01-01 |
| No annual figure between 2011-12-31 and 2013-12-31. | |||
| 2011-12-31 | -$6.98M | n/m | 2013-03-21, From 2011-01-01 |
| 2010-12-31 | -$8.33M | n/a | 2012-03-27, From 2010-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | 2025-12-31 | -$88.42M | n/a |
| Vanda Pharmaceuticals Inc. (VNDA) | 2025-12-31 | -$110.44M | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $238.50M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$116.63M | n/m |
| MapLight Therapeutics, Inc. (MPLT) | 2025-12-31 | -$138.61M | n/m |
| Enliven Therapeutics, Inc. (ELVN) | 2025-12-31 | -$70.46M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$43.98M | n/m |
| Rapport Therapeutics, Inc. (RAPP) | 2025-12-31 | -$88.09M | n/m |
| Biohaven Ltd. (BHVN) | 2025-12-31 | -$610.15M | n/m |
Compare ORKA, VNDA, TBPH, RYTM side by side · Screen every company in Pharmaceutical Preparations ↗